Semaglutide

Semaglutide is a GLP-1 receptor agonist investigated for its effects on glucose homeostasis and appetite regulation. Research suggests it may facilitate sustained weight loss and improve metabolic markers in studies involving overweight subjects. This peptide has become a major focus in metabolic research due to its potent effects on satiety signaling.